4.7 Review

Smart drug delivery systems for precise cancer therapy

Journal

ACTA PHARMACEUTICA SINICA B
Volume 12, Issue 11, Pages 4098-4121

Publisher

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2022.08.013

Keywords

Pharmaceutics; Smart drug delivery system; Stimuli-responsive; Receptor-ligand-based delivery; Nano-drug delivery systems; Precise therapy; Toxicity; Cancer

Funding

  1. National Natural Science Foundation of China [81973259, 82073789, 81803472]
  2. project for Innovative Research Group at Higher Educational Institutions in Chongqing (China) [CXQT20006]

Ask authors/readers for more resources

Nano-drug delivery systems play an important role in cancer treatment, but the balance between improved anticancer efficacy and reduced toxicity to normal tissues remains a challenge. Smart stimuli-responsive delivery strategies offer opportunities for advanced tumor specificity and controlled release behavior. The development of nanotechnology, material sciences, and biomedical sciences has enabled the creation of diverse and versatile smart drug delivery systems.
Nano-drug delivery strategies have been highlighted in cancer treatment, and much effort has been made in the optimization of bioavailability, biocompatibility, pharmacokinetics profiles, and in vivo distributions of anticancer nano-drug delivery systems. However, problems still exist in the delicate bal-ance between improved anticancer efficacy and reduced toxicity to normal tissues, and opportunities arise along with the development of smart stimuli-responsive delivery strategies. By on-demand responsiveness towards exogenous or endogenous stimulus, these smart delivery systems hold promise for advanced tumor-specificity as well as controllable release behavior in a spatial-temporal manner. Meanwhile, the blossom of nanotechnology, material sciences, and biomedical sciences has shed light on the diverse modern drug delivery systems with smart characteristics, versatile functions, and modification possibil-ities. This review summarizes the current progress in various strategies for smart drug delivery systems against malignancies and introduces the representative endogenous and exogenous stimuli-responsive smart delivery systems. It may provide references for researchers in the fields of drug delivery, biomate-rials, and nanotechnology.(c) 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available